ClinicalTrials.gg
CompletedNCT06632171Updated Nov 4, 2026

CBT-based and Motivational Interviewing Supported Psychoeducation in Obese Individuals

An interventional study of Cognitive Behavioral Therapy- Based and Motivational Interviewing-Supported Psychoeducation in Obesity, sponsored by Inonu University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by Inonu University · Not applicable, Interventional, and Treatment

How we know

Updated Nov 4, 2026Primary completion movedEnrollment updatedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
84
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 353 studies in Obesity with a site in Turkey — 73 open to participants now, 90 under way, 16 of them phase 3. Obesity · Turkey.

Enrollment
68th of 192
84 · median 64
Started
2024
with 37 others
No phase
161 of 353
29 open now
Registered
185th of 353
by date

Among the 353 studies in Obesity with a site in Turkey, this one is the 68th largest by enrollment of the 192 interventional ones that give a count, is one of 38 that started in 2024, is one of 161 with no phase, and was the 185th registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

73 of the 353 studies in Obesity with a site in Turkey are open now. Recruiting first, the newest first:

68 more — sign in →

All 73 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 353 studies in Obesity with a site in Turkey, or all of them as a file.
02

Study summary

The aim of this study was to examine the effects of cognitive-behavioral and motivational interviewing-supported psychoeducation on emotional eating and psychological resilience in individuals with obesity. The study was conducted using a randomized controlled experimental design. The initial planned sample size was 102 individuals, with 51 participants allocated to each group. However, due to difficulties in participant recruitment, a subsequent power analysis was conducted, which indicated a minimum total sample size of 32 participants. Ultimately, 84 individuals who met the inclusion criteria were randomized into the experimental (n = 42) and control (n = 42) groups, and 81 participants completed the study (experimental: n = 40; control: n = 41). A cognitive-behavioral and motivational interviewing-supported psychoeducation program was applied to the experimental group. Participants were evaluated at three time points: pre-test (baseline), post-test (8 weeks), and follow-up test (2 months after the post-test). No intervention was applied to the control group. The Emotional Eating Scale and Psychological Resilience Scale were used as data collection tools in the study. The study tested the hypothesis that the cognitive-behavioral and motivational interviewing-supported psychoeducation program would be effective in reducing emotional eating levels and increasing psychological resilience in individuals with obesity. The findings of the study may contribute to understanding the potential importance of psychological approaches in the treatment of obesity.

03

Conditions studied

  • Obesity

Keywords

  • Emotional Eating
  • Resilience
  • Obesity
  • Cognitive Behavioral Therapy
  • Motivational Interviewing
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Obese individuals ( 30 kg/m2 or more)
  • Between the ages of 18-65
  • Not having any psychiatric disorder or not using psychiatric medication
  • Volunteering to participate in psychoeducation
  • Being in a physical and mental condition that will allow them to adapt to treatment
  • Signing the form

Exclusion criteria

Exclusion Criteria:

  • Having communication problems
  • Having a medical condition (e.g. Cushing syndrome, hypothyroidism) or taking medication that causes obesity
  • Having a psychiatric diagnosis (e.g. depression, anxiety disorder, eating disorder) or taking psychotropic medication
  • Being pregnant or breastfeeding
  • Participating in another diet or exercise program
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
84 participants (actual)

Study arms

  • Experimental
    Psychoeducation Group

    Obese individuals in this group receive the structured cognitive behavioral therapy-based and motivational interviewing-supported psychoeducation program.

    Behavioral: Cognitive Behavioral Therapy- Based and Motivational Interviewing-Supported Psychoeducation

  • No intervention
    Control Group

    Obese individuals in this group did not receive any interventional procedure during the study period. Only assessment measurements were conducted for research purposes. After completion of follow-up assessments, the psychoeducation program was offered to those who requested it.

Interventions

  • BehavioralCognitive Behavioral Therapy- Based and Motivational Interviewing-Supported Psychoeducation

    An 8-week structured psychoeducation program based on cognitive behavioral therapy principles and supported by motivational interviewing techniques.

06

What researchers measure

Primary outcomes

  1. Emotional Eating Scale

    Emotional eating was assessed using the Emotional Eating Scale (EES). Scores range from 0 to 30; higher scores indicate a worse outcome (greater emotional eating).

    Time frame: Baseline; end of week 8 (post-intervention); 2-month follow-up

  2. Resilience scale

    Resilience was assessed using a resilience scale. Scores range from 0 to 84; higher scores indicate greater resilience (better outcome).

    Time frame: Baseline; post-intervention (end of week 8); 2-month follow-up

07

Study locations

1 site
  • Muş State Hospital and Muş Central Healthy Life Center
    Muş, Muş 49000, Turkey (Türkiye)
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2024 to primary completion in Aug 2025, 8 months.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's 8 months is below that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

Primary completion moved once since we started tracking on Sep 25, 2026: Jun 2025 → Aug 2025, on Nov 4, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Oct 6, 2024
First posted
Oct 8, 2024
StartActual
Nov 25, 2024
Primary completionActual
Aug 5, 2025was Jun 2025
CompletionActual
Aug 5, 2025
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jun 5, 2025→Aug 5, 2025
Nov 4, 2026
Enrollment
81→84
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    Primary completion Jun 5, 2025→Aug 5, 2025
    Enrollment 81→84
    + 2 other changes: verification date and description

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT06632171
Lead sponsor
Inonu University
Responsible party
Yusuf Durmuş (Lecturer, Inonu University) — Principal investigator
First posted
Oct 8, 2024
Start date
Nov 25, 2024
Primary completion
Aug 5, 2025
Completion
Aug 5, 2025
Last update
Nov 4, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion